Correction to: Population pharmacokinetics of PF ‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin ® ) in patients with HER2‑positive metastatic breast cancer

The article “Population pharmacokinetics of PF-05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin®) in patients with HER2-positive metastatic breast cancer ” written by Xiaoying Chen, Cheryl Li, Reginald Ewesuedo, Donghua Yin was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 3rd May 2019 without open access.

Source: Cancer Chemotherapy and Pharmacology - July 9, 2019 Category: Cancer & Oncology Source Type: research